Atara Biotherapeutics (ATRA) Moves to Buy: Rationale Behind the Upgrade
Atara Biotherapeutics (ATRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…
0,395$
-6,84%
Echtzeit-Aktienkurs Atara Biotherapeutics Inc.
Bid:
Ask:
Nachrichten zur Atara Biotherapeutics Inc. Aktie
Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 68.85% and 150.02%, respectively, for the quarter ended December 2024. Do…
Wall Street Analysts Think Atara Biotherapeutics (ATRA) Could Surge 33.03%: Read This Before Placing a Bet
The consensus price target hints at a 33% upside potential for Atara Biotherapeutics (ATRA). While empirical research shows that this…
Atara Biotherapeutics: Another Dip Buying Opportunity Following CRL For CMC Issues
…
Atara Biotherapeutics (ATRA) Upgraded to Buy: Heres Why
Atara Biotherapeutics (ATRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects.…
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Misses Revenue Estimates
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -148% and 40.70%, respectively, for the quarter ended June 2024. Do…